Table 3.
Parameter | Commercial/Medicare (N = 784) | Medicaid (N = 721) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
N (%) | Mean, $ | Median, $ | 95% CI | P value | N (%) | Mean, $ | Median, $ | 95% CI | P value | |
Age, yrs | ||||||||||
Children, 0–11 | 354 (45.2) | 7851.6 | 2955.0 | 5415.8–10,287.4 | <.049a | 302 (41.9) | 15,016.9 | 4547.8 | 9418.2–20,615.6 | <.001a |
Adolescents, 12–17 | 150 (19.1) | 5667.9 | 2222.1 | 3015.2–8320.7 | 120 (16.6) | 10,490.6 | 4580.6 | 7974.4–13,006.8 | ||
Adults, ≥18 | 280 (35.7) | 8752.2 | 2384.3 | 5649.0–11,855.4 | 299 (41.5) | 22,538.8 | 9701.7 | 19,158.0–25,919.5 | ||
Sex | ||||||||||
Male | 558 (71.2) | 7153.17 | 2619.2 | 5419.1–8887.2 | .584a | 582 (80.7) | 16,662.2 | 5973.3 | 14,142.0–19,182.5 | .135a |
Female | 226 (28.8) | 9242.54 | 2356.1 | 5492.9–12,992.2 | 139 (19.3) | 20,400.3 | 5153.6 | 10,521.6–30,279.1 | ||
Care received | ||||||||||
No treatment intervention | 24 (3.1) | 95.5 | 0.0 | 0–255.2 | NA | 13 (1.8) | 0.0 | 0.0 | − | NA |
Drug therapy only | 18 (2.3) | 664.9 | 246.2 | 175.8–1154.0 | 7 (1.0) | 1418.1 | 1577.9 | 115.8–2720.5 | ||
Procedure only | 186 (23.7) | 4466.2 | 1614.2 | 3415.7–5516.7 | 85 (11.8) | 7068.1 | 3063.9 | 5118.0–9018.2 | ||
Drug therapy and procedure | 556 (70.9) | 9416.0 | 3453.2 | 7148.0–11,684.1 | 616 (85.4) | 19,354.5 | 6641.7 | 16,143.0–22,566.0 | ||
Inpatient and outpatient costs | ||||||||||
Patients with hospitalizationa | 74 (9.4) | 21,676.7 | 7740.3 | 10,902.9–32,450.5 | NA | 90 (12.5) | 25,847.3 | 4467.7 | 11,363.0–40,331.6 | NA |
Patients with outpatient visita | 747 (95.3) | 4642.8 | 1751.4 | 3717.3–5568.3 | 702 (97.4) | 12,608.3 | 3355.2 | 10,957.9–14,258.8 |
Kruskal-Wallis test.
CI indicates confidence interval; NA, not available.